The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress
Open accessAbstract
Summary Glioblastoma (GBM), a mostly lethal brain tumor, acquires large amounts of free fatty acids (FAs) to promote cell growth. But how the cancer avoids lipotoxicity is unknown. Here, we identify that GBM upregulates diacylglycerol-acyltransferase 1 (DGAT1) to store excess FAs into triglycerides and lipid droplets. Inhibiting DGAT1 disrupted lipid homeostasis and resulted in excessive FAs moving into mitochondria for oxidation, leading to the generation of high levels of reactive oxygen species (ROS), mitochondrial damage, cytochrome c release and apoptosis. Adding N-acetyl-cysteine or inhibiting FA shuttling into mitochondria decreased ROS and cell death induced by DGAT1 inhibition. We show in xenograft models that targeting DGAT1 blocked lipid droplet formation, induced tumor cell apoptosis and markedly suppressed GBM growth. Together, our study demonstrates that DGAT1 upregulation protects GBM from oxidative damage and maintains lipid homeostasis by facilitating storage of excess FAs. Targeting DGAT1 could be a promising therapeutic approach for GBM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941 · cited 2×
“Lipid metabolism alterations are known to occur in various cancers (Cheng et al., 2018a; Cheng et al., 2018b; Currie et al., 2013a; Menendez and Lupu, 2007), but how tumor cells regulate lipid homoeostasis to prevent potential lipotoxicity have rarely been investigated.”
BackgroundCellular Fatty Acid Metabolism and Cancer
Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.017 · Cited by 2,123
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075
Self-citationAruoma, O. I., Halliwell, B., Hoey, B. M., & Butler, J. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90066-x · Cited by 1,772
Lipid Droplets and Cellular Lipid Metabolism
Walther, T. C., & Farese, R. V. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061009-102430 · Cited by 1,661
Cancer metabolism: fatty acid oxidation in the limelight
Carracedo, A., Cantley, L. C., & Pandolfi, P. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3483 · Cited by 1,324
Cases, S., Smith, S. J., Zheng, Y.-W., Myers, H. M., Lear, S. R., Sande, E., Novak, S., Collins, C., Welch, C. B., Lusis, A. J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13018 · Cited by 1,123
Thematic review series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis
Yen, C.-L. E., Stone, S. J., Koliwad, S., Harris, C., & Farese, R. V. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800018-jlr200 · Cited by 1,105
The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress
Lee, A. S. (2005) · Methods · doi:10.1016/j.ymeth.2004.10.010 · Cited by 991
Enzymes of triacylglycerol synthesis and their regulation
Coleman, R. (2004) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00051-1 · Cited by 965
Yue, S., Li, J., Lee, S.-Y., Lee, H. J., Shao, T., Song, B., Cheng, L., Masterson, T. A., Liu, X., Ratliff, T. L., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.019 · Cited by 929
GlioVis data portal for visualization and analysis of brain tumor expression datasets
Bowman, R. L., Wang, Q., Carro, A., Verhaak, R. G. W., & Squatrito, M. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now247 · Cited by 851
Lipid metabolism reprogramming and its potential targets in cancer
Cheng, C., Geng, F., Cheng, X., & Guo, D. (2018) · Cancer Communications · doi:10.1186/s40880-018-0301-4 · Cited by 850
Self-citationCloning of DGAT2, a Second Mammalian Diacylglycerol Acyltransferase, and Related Family Members
Cases, S., Stone, S. J., Zhou, P., Yen, E., Tow, B., Lardizabal, K. D., Voelker, T., & Farese, R. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106219200 · Cited by 818
Mao, P., Joshi, K., Li, J., Kim, S.-H., Li, P., Santana-Santos, L., Luthra, S., Chandran, U. R., Benos, P. V., Smith, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221478110 · Cited by 642
Nguyen, T. B., Louie, S. M., Daniele, J. R., Tran, Q., Dillin, A., Zoncu, R., Nomura, D. K., & Olzmann, J. A. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.06.003 · Cited by 610
Cross, B. C. S., Bond, P. J., Sadowski, P. G., Jha, B. K., Zak, J., Goodman, J. M., Silverman, R. H., Neubert, T. A., Baxendale, I. R., Ron, D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115623109 · Cited by 591
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Qu, Q., Zeng, F., Liu, X., Wang, Q. J., & Deng, F. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.132 · Cited by 545
Ertunc, M. E., & Hotamisligil, G. S. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066514 · Cited by 488
Balancing the fat: lipid droplets and human disease
Krahmer, N., Farese, R. V., & Walther, T. C. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201100671 · Cited by 474
CHOP is a multifunctional transcription factor in the ER stress response
Nishitoh, H. (2012) · Journal of Biochemistry · doi:10.1093/jb/mvr143 · Cited by 469
Watson, A. D. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600022-jlr200 · Cited by 455
Guo, D., Reinitz, F., Youssef, M., Hong, C., Nathanson, D., Akhavan, D., Kuga, D., Amzajerdi, A. N., Soto, H., Zhu, S., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0102 · Cited by 452 · cited 1×
“We previously uncovered that de novo FA synthesis is greatly increased in GBM to support its rapid growth (Cheng et al., 2015; Geng et al., 2016; Guo, 2016; Guo et al., 2013; Guo et al., 2014; Guo et al., 2009a; Guo et al., 2009b; Guo et al., 2011; Ru and Guo, 2017; Ru et al., 2016).”
BackgroundSelf-citationCharacterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity
Atkins, C., Liu, Q., Minthorn, E., Zhang, S.-Y., Figueroa, D. J., Moss, K., Stanley, T. B., Sanders, B., Goetz, A., Gaul, N., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3109 · Cited by 443
Single-vector inducible lentiviral RNAi system for oncology target validation
Wiederschain, D., Susan, W., Chen, L., Loo, A., Yang, G., Huang, A., Chen, Y., Caponigro, G., Yao, Y.-M., Lengauer, C., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.3.7701 · Cited by 441
Yang, K., Cheng, H., Gross, R. W., & Han, X. (2009) · Analytical Chemistry · doi:10.1021/ac900241u · Cited by 415
Self-citationQiu, B., Ackerman, D., Sanchez, D. J., Li, B., Ochocki, J. D., Grazioli, A., Bobrovnikova-Marjon, E., Diehl, J. A., Keith, B., & Simon, M. C. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1507 · Cited by 394
Accioly, M. T., Pacheco, P., Maya-Monteiro, C. M., Carrossini, N., Robbs, B. K., Oliveira, S. S., Kaufmann, C., Morgado-Diaz, J. A., Bozza, P. T., & Viola, J. P. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1999 · Cited by 365
Triglyceride Synthesis by DGAT1 Protects Adipocytes from Lipid-Induced ER Stress during Lipolysis
Chitraju, C., Mejhert, N., Haas, J. T., Diaz-Ramirez, L. G., Grueter, C. A., Imbriglio, J. E., Pinto, S., Koliwad, S. K., Walther, T. C., & Farese, R. V. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.012 · Cited by 364
Guo, D., Prins, R. M., Dang, J., Kuga, D., Iwanami, A., Soto, H., Lin, K. Y., Huang, T. T., Akhavan, D., Hock, M. B., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000446 · Cited by 351
Self-citationEfficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1
Herker, E., Harris, C., Hernandez, C., Carpentier, A., Kaehlcke, K., Rosenberg, A. R., Farese, R. V., & Ott, M. (2010) · Nature Medicine · doi:10.1038/nm.2238 · Cited by 350
DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes
Harris, C. A., Haas, J. T., Streeper, R. S., Stone, S. J., Kumari, M., Yang, K., Han, X., Brownell, N., Gross, R. W., Zechner, R., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m013003 · Cited by 346
Self-citationMammalian Triacylglycerol Metabolism: Synthesis, Lipolysis, and Signaling
Coleman, R. A., & Mashek, D. G. (2011) · Chemical Reviews · doi:10.1021/cr100404w · Cited by 330
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
Geng, F., Cheng, X., Wu, X., Yoo, J. Y., Cheng, C., Guo, J. Y., Mo, X., Ru, P., Hurwitz, B., Kim, S.-H., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2973 · Cited by 328
Self-citationTargeting SREBP-1-driven Lipid Metabolism to Treat Cancer
Guo, D., Bell, E., Mischel, P., & Chakravarti, A. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990486 · Cited by 323
Self-citationGlucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
Cheng, C., Ru, P., Geng, F., Liu, J., Yoo, J. Y., Wu, X., Cheng, X., Euthine, V., Hu, P., Guo, J. Y., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.021 · Cited by 320
Self-citationTriglycerides Promote Lipid Homeostasis during Hypoxic Stress by Balancing Fatty Acid Saturation
Ackerman, D., Tumanov, S., Qiu, B., Michalopoulou, E., Spata, M., Azzam, A., Xie, H., Simon, M. C., & Kamphorst, J. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.015 · Cited by 305
Regulatory enzymes of mitochondrial β‐oxidation as targets for treatment of the metabolic syndrome
Schreurs, M., Kuipers, F., & Van Der Leij, F. R. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00642.x · Cited by 296
Progress in glioma diagnosis, classification and treatment
Wen, P. Y., & Reardon, D. A. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.242 · Cited by 283
Deregulated MYC expression induces dependence upon AMPK-related kinase 5
Liu, L., Ulbrich, J., Müller, J., Wüstefeld, T., Aeberhard, L., Kress, T. R., Muthalagu, N., Rycak, L., Rudalska, R., Moll, R., et al. (2012) · Nature · doi:10.1038/nature10927 · Cited by 276
Novel advances in shotgun lipidomics for biology and medicine
Wang, M., Wang, C., Han, R. H., & Han, X. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.12.002 · Cited by 271
Self-citationFatty acid oxidation is required for the respiration and proliferation of malignant glioma cells
Lin, H., Patel, S., Affleck, V. S., Wilson, I., Turnbull, D. M., Joshi, A. R., Maxwell, R., & Stoll, E. A. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now128 · Cited by 260
Guo, D., Hildebrandt, I. J., Prins, R. M., Soto, H., Mazzotta, M. M., Dang, J., Czernin, J., Shyy, J. Y.-J., Watson, A. D., Phelps, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906606106 · Cited by 232
Self-citationLipid metabolism emerges as a promising target for malignant glioma therapy
Guo, D., Bell, E. H., & Chakravarti, A. (2013) · CNS Oncology · doi:10.2217/cns.13.20 · Cited by 201
Self-citationNohturfft, A., Brown, M. S., & Goldstein, J. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.17243 · Cited by 191
Han, X., Yang, K., & Gross, R. W. (2008) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3595 · Cited by 190 · cited 3×
“…and the mass spectrometric analysis was performed on a QqQ mass spectrometer (Thermo Scientific TSQ Altis) and high-resolution, accurate-mass mass spectrometer (Thermo Scientific Q Exactive) equipped with automated nanospray device (TriVersa NanoMate), as previously described (Han et al., 2008).”
BackgroundMethodSelf-citationAcyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation
Duman, C., Yaqubi, K., Hoffmann, A., Acikgöz, A. A., Korshunov, A., Bendszus, M., Herold-Mende, C., Liu, H.-K., & Alfonso, J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.04.004 · Cited by 188
The nutrient environment affects therapy
Muir, A., & Heiden, M. G. V. (2018) · Science · doi:10.1126/science.aar5986 · Cited by 161
SCAP/SREBPs are Central Players in Lipid Metabolism and Novel Metabolic Targets in Cancer Therapy
Cheng, X., Li, J., & Guo, D. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180523104541 · Cited by 146
Self-citationZhao, G., Souers, A. J., Voorbach, M. J., Falls, H. D., Droz, B. A., Brodjian, S. J., Lau, Y. Y., Iyengar, R. R., Gao, J., Judd, A. S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7013887 · Cited by 139
Uchida, H., Marzulli, M., Nakano, K., Goins, W. F., Chan, J., Hong, C., Mazzacurati, L., Yoo, J. Y., Haseley, A., Nakashima, H., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.211 · Cited by 133
Weis, B. C., Cowan, A. T., Brown, N., Foster, D. W., & McGarry, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47214-6 · Cited by 121
Isolation of a cDNA clone encoding subunit IV of human cytochrome c oxidase
Zeviani, M., Nakagawa, M., Herbert, J., Lomax, M. I., Grossman, L. I., Sherbany, A. A., Miranda, A. F., DiMauro, S., & Schon, E. A. (1987) · Gene · doi:10.1016/0378-1119(87)90281-2 · Cited by 110
Multidimensional Mass Spectrometry-Based Shotgun Lipidomics
Wang, M., & Han, X. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1258-2_13 · Cited by 99
Self-citationFutatsugi, K., Kung, D. W., Orr, S. T. M., Cabral, S., Hepworth, D., Aspnes, G., Bader, S., Bian, J., Boehm, M., Carpino, P. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01006 · Cited by 88
Lipid droplets, potential biomarker and metabolic target in glioblastoma
Guo, D. (2017) · Internal Medicine Review · doi:10.18103/imr.v3i5.443 · Cited by 87
Self-citationLipidomics: Comprehensive Mass Spectrometry of Lipids
Han, X. (2016) · Cited by 86
Self-citationRu, P., Hu, P., Geng, F., Mo, X., Cheng, C., Yoo, J., Cheng, X., Wu, X.-N., Guo, J., Nakano, I., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.017 · Cited by 76
Self-citationClassical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2
Londhe, P., Yu, P. Y., Ijiri, Y., Ladner, K. J., Fenger, J. M., London, C. A., Houghton, P. J., & Guttridge, D. C. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00104 · Cited by 72
Kwong, S. C., Jamil, A. H. A., Rhodes, A., Taib, N. A. M., & Chung, I. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m092379 · Cited by 56
Cvrljevic, A. N., Akhavan, D., Wu, M., Martinello, P., Furnari, F. B., Johnston, A. J., Guo, D., Pike, L. S., Cavenee, W. K., Scott, A. M., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.083295 · Cited by 51
Self-citationNaik, R., Brice, O.-O., Kim, M., Choi, Y., Lee, H. S., & Lee, K. (2014) · ChemMedChem · doi:10.1002/cmdc.201402069 · Cited by 46
King, A. J., Segreti, J. A., Larson, K. J., Souers, A. J., Kym, P. R., Reilly, R. M., Collins, C. A., Voorbach, M. J., Zhao, G., Mittelstadt, S. W., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.056 · Cited by 38
microRNA-29 mediates a novel negative feedback loop to regulate SCAP/SREBP-1 and lipid metabolism
Ru, P., & Guo, D. (2017) · RNA & DISEASE · doi:10.14800/rd.1525 · Cited by 36
Self-citationSCAP links glucose to lipid metabolism in cancer cells
Guo, D. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1132120 · Cited by 29
Self-citationLipidomics Profiling of Myelin
Wang, C., Pablo Palavicini, J., & Han, X. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7862-5_4 · Cited by 15
Self-citation
Cited by
Bian, X., Liu, R., Meng, Y., Xing, D., Xu, D., & Lu, Z. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201606 · Cited by 983
Lipid droplet biogenesis and functions in health and disease
Zadoorian, A., Du, X., & Yang, H. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00845-0 · Cited by 617
Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity
Yoon, H., Shaw, J. L., Haigis, M. C., & Greka, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.027 · Cited by 510
Dierge, E., Debock, E., Guilbaud, C., Corbet, C., Mignolet, E., Mignard, L., Bastien, E., Dessy, C., Larondelle, Y., & Feron, O. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.05.016 · Cited by 496
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
Jin, H.-R., Wang, J., Wang, Z.-J., Xi, M.-J., Xia, B.-H., Deng, K., & Yang, J.-L. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01498-2 · Cited by 481
Metadata
- Authors
- Cheng, X., Geng, F., Pan, M., Wu, X., Zhong, Y., Wang, C., Tian, Z., Cheng, C., Zhang, R., Puduvalli, V., Horbinski, C., Mo, X., Han, X., Chakravarti, A., & Guo, D.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 32
- Issue
- 2
- Pages
- 229-242.e8
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W3036220131
- Cited by
- 347
- References
- 68
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.